UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 119 filers reported holding UNIQURE NV in Q2 2024. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,203,645 | -6.7% | 1,161,528 | +8.3% | 0.00% | – |
Q1 2024 | $5,577,187 | -14.4% | 1,072,536 | +11.4% | 0.00% | – |
Q4 2023 | $6,518,129 | +1.9% | 962,796 | +1.0% | 0.00% | – |
Q3 2023 | $6,397,556 | -60.0% | 953,436 | -31.7% | 0.00% | – |
Q2 2023 | $15,989,748 | -43.7% | 1,395,266 | -1.0% | 0.00% | -100.0% |
Q1 2023 | $28,390,673 | -11.3% | 1,409,666 | -0.1% | 0.00% | 0.0% |
Q4 2022 | $31,997,821 | +18.9% | 1,411,461 | -1.6% | 0.00% | 0.0% |
Q3 2022 | $26,903,000 | +11.7% | 1,434,004 | +10.9% | 0.00% | 0.0% |
Q2 2022 | $24,095,000 | +10.2% | 1,292,622 | +6.8% | 0.00% | 0.0% |
Q1 2022 | $21,861,000 | -10.7% | 1,209,840 | +2.5% | 0.00% | 0.0% |
Q4 2021 | $24,469,000 | -35.7% | 1,179,787 | -0.8% | 0.00% | 0.0% |
Q3 2021 | $38,052,000 | +69.8% | 1,188,764 | +63.4% | 0.00% | 0.0% |
Q2 2021 | $22,409,000 | -5.9% | 727,574 | +3.0% | 0.00% | 0.0% |
Q1 2021 | $23,809,000 | -3.0% | 706,717 | +4.1% | 0.00% | 0.0% |
Q4 2020 | $24,537,000 | +4.0% | 679,131 | +6.1% | 0.00% | 0.0% |
Q3 2020 | $23,584,000 | +297.8% | 640,376 | +386.8% | 0.00% | – |
Q2 2020 | $5,928,000 | -5.2% | 131,555 | -0.2% | 0.00% | – |
Q1 2020 | $6,255,000 | -30.6% | 131,827 | +4.8% | 0.00% | – |
Q4 2019 | $9,014,000 | +97.8% | 125,789 | +8.6% | 0.00% | – |
Q3 2019 | $4,558,000 | -32.8% | 115,795 | +33.3% | 0.00% | – |
Q2 2019 | $6,787,000 | +50.8% | 86,849 | +15.1% | 0.00% | – |
Q1 2019 | $4,500,000 | +108.7% | 75,434 | +0.8% | 0.00% | – |
Q4 2018 | $2,156,000 | -41.9% | 74,799 | -26.7% | 0.00% | – |
Q3 2018 | $3,712,000 | +0.2% | 101,992 | +4.1% | 0.00% | – |
Q2 2018 | $3,704,000 | +227.5% | 98,000 | +103.7% | 0.00% | – |
Q1 2018 | $1,131,000 | +104.2% | 48,107 | +70.0% | 0.00% | – |
Q4 2017 | $554,000 | – | 28,299 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 939,966 | $21,309,029 | 5.53% |
Aquilo Capital Management, LLC | 624,854 | $14,165,440 | 5.32% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 631,500 | $14,297,160 | 4.42% |
Nantahala Capital Management | 2,700,239 | $61,214,418 | 3.97% |
Integral Health Asset Management, LLC | 550,000 | $12,468,500 | 2.62% |
Privium Fund Management B.V. | 301,298 | $6,830,426 | 2.59% |
683 Capital Management, LLC | 1,145,000 | $25,957,150 | 2.20% |
PFM Health Sciences, LP | 2,302,314 | $52,193,458 | 1.87% |
Nantahala Capital Management | 1,187,700 | $26,925,159 | 1.74% |
Jetstream Capital LLC | 30,000 | $680,100 | 1.44% |